 | AstraZeneca vaccine as third dose effective against Omicron: StudyThe results were observed among individuals previously vaccinated with either Vaxzevria or an mRNA vaccine. |
 | Serum Institute applies to Indian authorities for full market authorisation of CovishieldSII had partnered with the developer of Covishield, AstraZeneca, for the supply of the vaccine to the Indian government, which had in January this year granted emergency use authorisation. |
 | Asia keeps omicron at bay, but a surge may be inevitableCountries such as Japan, South Korea, China and Thailand quickly reinstated entry and quarantine restrictions in recent weeks after relaxing them in the fall. |
 | Oxford/AstraZeneca vaccine behind lower COVID deaths in UK, says expertAccording to Our World in Data, a website run by the University of Oxford, the UK has 1.7 daily deaths from COVID per million people. |
 | Third dose of Covishield significantly boosts antibodies against Omicron: StudyThe study found that antibody levels against Omicron after the booster shot were higher than antibodies in people who had been infected with and recovered naturally from Covid-19. |
| AstraZeneca Covid vaccine protection wanes after three months: Lancet studyResearchers analysed data for two million people in Scotland and 42 million people in Brazil who had been vaccinated with the AstraZeneca vaccine. |
| AstraZeneca’s Evusheld therapy may be effective against Omicron: StudyEvusheld has also received authorisations in other countries, the pharma major said, adding that it is now working with regulators on applications for the use of Evusheld in treating Covid. |
| USFDA study shows Evusheld retains neutralising activity against Omicron: AstraZenecaEvusheld is a long-acting antibody combination for the prevention of COVID-19. |
 | Amid vaccine alliance chief's warning, Israel to assist inoculation drive at African nationsThe Foreign Ministry said the AstraZeneca vaccines would be transferred in the coming weeks, a decision that was part of Israel's strengthening ties with the African countries. |
 | Next virus could be more lethal, warns Oxford University COVID vaccine creatorGilbert, who was made a Dame by Queen Elizabeth II for her pivotal role in developing the Oxford/AstraZeneca vaccine, said there needed to be more funding for pandemic preparedness. |
| Next virus to hit humankind could be more lethal, warns Oxford-AstraZeneca vaccine creatorSpeaking about the Omicron variant of the novel coronavirus, she said its spike protein contained mutations known to increase the transmissibility of the virus. |
| AstraZeneca opens research centre as UK builds science hubThe 19,000 square-meter (more than 200,000 square-foot) complex will house more than 2,200 research scientists. |
 | AstraZeneca set for 'modest' profit from sold COVID-19 vaccinesThe Oxford/AstraZeneca vaccine, which is also being manufactured by the Serum Institute of India (SII) as part of an agreement, has until now been sold on a not-for-profit basis. |
 | US to allow international visitors, here are the new travel rulesThe new rules allow air travel from previously restricted countries as long as the traveller has proof of being jabbed with any WHO-recognized vaccine and a negative COVID-19 test. |
 | AstraZeneca withdraws request for Swiss approval of universal COVID shotSwitzerland has cleared the BioNTech-Pfizer, Moderna and Johnson & Johnson vaccines for use. |
